OrbiMed’s AbCellera Biologics ABCL Stock Holding History

OrbiMed’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,344,568	Closed	-$11.5M	–	110
2025 Q2	$11.5M	Sell	3,344,568 -836,200	-20%	-$2.08M	0.29%	56
2025 Q1	$9.32M	Hold	4,180,768	–	–	0.22%	64
2024 Q4	$12.2M	Hold	4,180,768	–	–	0.25%	68
2024 Q3	$10.9M	Hold	4,180,768	–	–	0.2%	78
2024 Q2	$12.4M	Hold	4,180,768	–	–	0.25%	68
2024 Q1	$18.9M	Hold	4,180,768	–	–	0.35%	67
2023 Q4	$23.9M	Hold	4,180,768	–	–	0.48%	60
2023 Q3	$19.2M	Hold	4,180,768	–	–	0.41%	64
2023 Q2	$27M	Hold	4,180,768	–	–	0.49%	61
2023 Q1	$31.5M	Hold	4,180,768	–	–	0.62%	53
2022 Q4	$42.4M	Hold	4,180,768	–	–	0.81%	47
2022 Q3	$41.3K	Hold	4,180,768	–	–	0.77%	48
2022 Q2	$44.5K	Hold	4,180,768	–	–	0.81%	40
2022 Q1	$40.8M	Hold	4,180,768	–	–	0.66%	44
2021 Q4	$59.8M	Hold	4,180,768	–	–	0.77%	43
2021 Q3	$83.8M	Sell	4,180,768 -2,042,251	-33%	-$36.1M	0.92%	33
2021 Q2	$137M	Sell	6,223,019 -1,977,749	-24%	-$54.5M	1.39%	20
2021 Q1	$278M	Sell	8,200,768 -200,000	-2%	-$7.97M	2.61%	9
2020 Q4	$338M	Buy	+8,400,768	New	+$384M	2.96%	5

Other funds holding ABCL

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return